Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones

Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones

Bibliographic Details
Main Authors:	Al-Mawali, Adhra, Gillis, David, Lewis, Ian
Format:	Online
Language:	English
Published:	BioMed Central 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964068/

Similar Items

CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia
by: Jiang, Zhiwu, et al.
Published: (2016)

Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia
by: Wobus, Manja, et al.
Published: (2015)

Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin
Published: (1996)

Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells
Published: (1994)

Dual inhibition of AKT/FLT3-ITD by A674563 overcomes FLT3 ligand-induced drug resistance in FLT3-ITD positive AML
by: Wang, Aoli, et al.
Published: (2016)

Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development
Published: (1993)

Diagnostic Challenges of CD4+/CD56+/CD123+ hematological neoplasms*
by: Thiago, Leandro S., et al.
Published: (2013)

A molecular signature of dormancy in CD34+CD38- acute myeloid leukaemia cells
by: Al-Asadi, Mazin Gh., et al.
Published: (2017)

Interest in Determining the CD34+ CD38− Phenotype in the Diagnosis and Prognosis of Acute Leukemia in Abidjan – Côte d’Ivoire
by: Sawadogo, Duni, et al.
Published: (2013)

Wnt1 Accelerates an Ex Vivo Expansion of Human Cord Blood CD34+CD38− Cells
by: Chotinantakul, Kamonnaree, et al.
Published: (2013)

Effect of DLK1 on tumorigenesis in CD34+CD38− bone marrow cells in myelodysplastic syndromes
by: ZHANG, WEI, et al.
Published: (2013)

Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
by: Jawad, Mays, et al.
Published: (2012)

Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38- Stem-Like Cells
by: Kornblau, Steven M., et al.
Published: (2013)

Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized
by: Jiang, Zhiwu, et al.
Published: (2016)

FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia
by: Takenokuchi, Mariko, et al.
Published: (2012)

Overcoming AC220 resistance of FLT3-ITD by SAR302503
by: Kesarwani, M, et al.
Published: (2013)

Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia
by: Pillinger, Genevra, et al.
Published: (2015)

Feature genes predicting the FLT3/ITD mutation in acute myeloid leukemia
by: LI, CHENGLONG, et al.
Published: (2016)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
by: Fritzenwanger, M, et al.
Published: (2009)

Combined Characterization of microRNA and mRNA Profiles Delineates Early Differentiation Pathways of CD133+ and CD34+ Hematopoietic Stem and Progenitor Cells
by: Bissels, Ute, et al.
Published: (2011)

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia
by: Green, Alexa S., et al.
Published: (2015)

Adoptive immunotherapy for AML with CD123-engager T cells
by: Bonifant, Challice, et al.
Published: (2015)

Thyrotropin Regulates IL-6 Expression in CD34+ Fibrocytes: Clear Delineation of Its cAMP-Independent Actions
by: Raychaudhuri, Nupur, et al.
Published: (2013)

Characterization of anticoagulant heparinoids by immunoprofiling
by: Wijnhoven, Tessa J., et al.
Published: (2007)

Quantitative fragment analysis of FLT3-ITD efficiently identifying poor prognostic group with high mutant allele burden or long ITD length
by: Kim, Y, et al.
Published: (2015)

FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome
by: Wang, Libing, et al.
Published: (2013)

A novel Lin−CD34+CD38− integrin α2− bipotential megakaryocyte–erythrocyte progenitor population in the human bone marrow
by: Wong, W M, et al.
Published: (2016)

Direct confirmation of quiescence of CD34+CD38- leukemia stem cell populations using single cell culture, their molecular signature and clinicopathological implications
by: Won, Eun Jeong, et al.
Published: (2015)

Glycyrrhetinic Acid Induces Apoptosis in Leukemic HL60 Cells Through Upregulating of CD95/ CD178
by: Pirzadeh, Sara, et al.
Published: (2014)

Leukemic Phase of CD5+ Diffuse Large B-Cell Lymphoma
by: Hui Hua Hsiao, et al.
Published: (2018-08-01)

A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
by: Horenstein, Alberto L, et al.
Published: (2013)

Id2 expression delineates differential checkpoints in the genetic program of CD8α+ and CD103+ dendritic cell lineages
by: Jackson, Jacob T, et al.
Published: (2011)

Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients
by: Zuffa, Elisa, et al.
Published: (2015)

The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia
by: M. Kamazani, Fatemeh, et al.
Published: (2014)

Ligation of CD38 suppresses human B lymphopoiesis
Published: (1995)

The Roles of Oxytocin and CD38 in Social or Parental Behaviors
by: Lopatina, Olga, et al.
Published: (2013)

Immuno-targeting the multifunctional CD38 using nanobody
by: Li, Ting, et al.
Published: (2016)

Plerixafor for autologous CD34+ cell mobilization
by: Salman, Huda, et al.
Published: (2011)

Adipocytokines and CD34+ Progenitor Cells in Alzheimer's Disease
by: Bigalke, Boris, et al.
Published: (2011)

CD34 Expression in the Stromal Cells of Alveolar Adenoma
by: De Rosa, Nicolina, et al.
Published: (2012)